This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
bacteria:t3e:xopj5 [2020/07/08 18:08] – [References] rkoebnik | bacteria:t3e:xopj5 [2025/02/13 11:49] (current) – jfpothier | ||
---|---|---|---|
Line 1: | Line 1: | ||
- | ====== XopJ5 ====== | + | ====== |
Author: [[https:// | Author: [[https:// | ||
- | Internal reviewer: [[https:// | + | Internal reviewer: [[https:// |
- | Expert reviewer: FIXME | + | |
Class: XopJ\\ | Class: XopJ\\ | ||
Family: XopJ5\\ | Family: XopJ5\\ | ||
Prototype: AvrXccB (// | Prototype: AvrXccB (// | ||
- | RefSeq | + | GenBank |
+ | RefSeq ID: [[https:// | ||
Synonym: AvrXccB\\ | Synonym: AvrXccB\\ | ||
3D structure: Unknown | 3D structure: Unknown | ||
Line 20: | Line 20: | ||
=== (Experimental) evidence for being a T3E === | === (Experimental) evidence for being a T3E === | ||
- | T3E-defective mutant was not capable | + | Using the HR-inducing domain AvrBs1< |
+ | AvrXccB, fused to a HA tag, was shown to be secreted into culture supernatants by Western blot analysis using an anti‐haemagglutinin (HA) antibody. In contrast, a T3E-defective mutant was not capable of secreting this effector (Liu //et al//., 2017). | ||
=== Regulation === | === Regulation === | ||
- | The //xopE1// < | + | The //xopE1// < |
=== Phenotypes === | === Phenotypes === | ||
- | AvrXccB (XopJ5< | + | * AvrXccB (XopJ5< |
+ | * XopJ5 was found to be associated with variations in disease symptoms when testing a set of 45 //X. campestris// | ||
+ | * Experimental evidence using heterologous expression of //avrXccB// suggests that this protein is involved in the suppression of plant immunity. Immunity suppression in // | ||
=== Localization === | === Localization === | ||
- | Membrane, confirmed experimentally through GFP-tagged AvrXccB expression in transgenic // | + | Plant plasma membrane, confirmed experimentally through GFP-tagged AvrXccB expression in transgenic // |
=== Enzymatic function === | === Enzymatic function === | ||
Cysteine protease/ | Cysteine protease/ | ||
+ | |||
=== Interaction partners === | === Interaction partners === | ||
- | AvrXccB interacts with SAM-MT1 in // | + | AvrXccB interacts |
===== Conservation ===== | ===== Conservation ===== | ||
Line 42: | Line 49: | ||
Yes. YopJ-like effectors such as AvrBsT in //Xcv// or //Xcc//, XopJ in //Xcv//. | Yes. YopJ-like effectors such as AvrBsT in //Xcv// or //Xcc//, XopJ in //Xcv//. | ||
+ | |||
=== In other plant pathogens/ | === In other plant pathogens/ | ||
Yes. YopJ-like effectors HopZ1a in //P. syringae// and Pop2 in //R. solanacearum// | Yes. YopJ-like effectors HopZ1a in //P. syringae// and Pop2 in //R. solanacearum// | ||
+ | |||
===== References ===== | ===== References ===== | ||
da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, Quaggio RB, Monteiro-Vitorello CB, Van Sluys MA, Almeida NF, Alves LM, do Amaral AM, Bertolini MC, Camargo LE, Camarotte G, Cannavan F, Cardozo J, Chambergo F, Ciapina LP, Cicarelli RM, Coutinho LL, Cursino-Santos JR, El-Dorry H, Faria JB, Ferreira AJ, Ferreira RC, Ferro MI, Formighieri EF, Franco MC, Greggio CC, Gruber A, Katsuyama AM, Kishi LT, Leite RP, Lemos EG, Lemos MV, Locali EC, Machado MA, Madeira AM, Martinez-Rossi NM, Martins EC, Meidanis J, Menck CF, Miyaki CY, Moon DH, Moreira LM, Novo MT, Okura VK, Oliveira MC, Oliveira VR, Pereira HA, Rossi A, Sena JA, Silva C, de Souza RF, Spinola LA, Takita MA, Tamura RE, Teixeira EC, Tezza RI, Trindade dos Santos M, Truffi D, Tsai SM, White FF, Setubal JC, Kitajima JP (2002). Comparison of the genomes of two // | da Silva AC, Ferro JA, Reinach FC, Farah CS, Furlan LR, Quaggio RB, Monteiro-Vitorello CB, Van Sluys MA, Almeida NF, Alves LM, do Amaral AM, Bertolini MC, Camargo LE, Camarotte G, Cannavan F, Cardozo J, Chambergo F, Ciapina LP, Cicarelli RM, Coutinho LL, Cursino-Santos JR, El-Dorry H, Faria JB, Ferreira AJ, Ferreira RC, Ferro MI, Formighieri EF, Franco MC, Greggio CC, Gruber A, Katsuyama AM, Kishi LT, Leite RP, Lemos EG, Lemos MV, Locali EC, Machado MA, Madeira AM, Martinez-Rossi NM, Martins EC, Meidanis J, Menck CF, Miyaki CY, Moon DH, Moreira LM, Novo MT, Okura VK, Oliveira MC, Oliveira VR, Pereira HA, Rossi A, Sena JA, Silva C, de Souza RF, Spinola LA, Takita MA, Tamura RE, Teixeira EC, Tezza RI, Trindade dos Santos M, Truffi D, Tsai SM, White FF, Setubal JC, Kitajima JP (2002). Comparison of the genomes of two // | ||
+ | |||
+ | Guy E, Genissel A, Hajri A, Chabannes M, David P, Carrere S, Lautier M, Roux B, Boureau T, Arlat M, Poussier S, Noël LD (2013). Natural genetic variation of // | ||
Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // | Jiang W, Jiang BL, Xu RQ, Huang JD, Wei HY, Jiang GF, Cen WJ, Liu J, Ge YY, Li GH, Su LL, Hang XH, Tang DJ, Lu GT, Feng JX, He YQ, Tang JL (2009). Identification of six type III effector genes with the PIP box in // | ||
Line 57: | Line 68: | ||
Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | Thieme F, Szczesny R, Urban A, Kirchner O, Hause G, Bonas U (2007). New type III effectors from // | ||
- | ===== Further reading | + | ===== Acknowledgements |
- | Guy E, Genissel A, Hajri A, Chabannes M, David P, Carrere S, Lautier M, Roux B, Boureau T, Arlat M, Poussier S, Noël LD (2013). Natural genetic variation of // | + | This fact sheet is based upon work from COST Action CA16107 EuroXanth, supported by COST (European Cooperation in Science |